Weight-loss injections may trigger a new cycle of yo-yo dieting, experts warn
Researchers caution that popular injectable weight-loss drugs could fuel a fresh pattern of weight cycling in some users.

A growing wave of people turning to injectable weight-loss medications could be setting the stage for a new form of yo-yo dieting, researchers and clinicians have suggested. The drugs, originally developed for type 2 diabetes, have gained mainstream popularity for their ability to suppress appetite and produce rapid drops in body weight. However, emerging observations indicate that some users may struggle to maintain results once treatment is paused or scaled back.
Why the cycle can restart
Weight-loss injections work by mimicking hormones that regulate hunger, helping users feel full for longer and consume fewer calories. When the medication is stopped, appetite signals typically return to pre-treatment levels, sometimes more intensely, leading to rapid weight regain. Specialists describe this pattern as a pharmacologically assisted version of yo-yo dieting, where loss and regain are tied to drug access rather than purely behavioural habits.
Concerns from clinicians
Medical professionals note that repeated weight cycling has been linked in broader research to metabolic stress, cardiovascular strain and psychological distress. They argue that patients considering these injections should be counselled about the possibility of regain and the importance of long-term lifestyle planning.
- Appetite often rebounds after treatment ends, increasing the risk of regaining lost weight.
- Some users report difficulty discontinuing the drugs without significant weight returning.
- Researchers emphasise pairing medication with structured diet and physical-activity habits.
What researchers recommend
Experts are calling for clearer guidance on tapering protocols and post-treatment maintenance strategies. Several are exploring how approaches such as identifying factors behind midlife weight gain in men, and broader methods like a clinical approach to sustainable weight management and vitality, can support patients after they stop the injections. Others point to emerging evidence that supporting gut health could help with weight-loss efforts, offering a complementary route during the transition off medication.